Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02348255
What this trial is testing

NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse

Who this might be right for
Adult Brain GlioblastomaRecurrent Adult Brain Neoplasm
University of California, Davis
Early research (Phase 1)UnknownNCT00591058
What this trial is testing

Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeGBM+2 more
TransMolecular 36
Testing effectiveness (Phase 2)Study completedNCT00540176
What this trial is testing

The Safety and Efficacy of DCA for the Treatment of Brain Cancer

Who this might be right for
Malignant Gliomas, Glioblastoma Multiforme
University of Alberta 40
Testing effectiveness (Phase 2)Looking for participantsNCT02861898
What this trial is testing

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaBrain CancerBrain Neoplasm+4 more
Northwell Health 33
Testing effectiveness (Phase 2)Ended earlyNCT00548938
What this trial is testing

Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM

Who this might be right for
Glioblastoma MultiformeHigh-Grade Glioma
Methodist Healthcare - Memphis 40
Not applicableLooking for participantsNCT07023640
What this trial is testing

Application of the CD73-Targeted Probe ⁶⁸Ga-DOTA-mPNE PET/CT Imaging in the Diagnosis of Malignant Tumors

Who this might be right for
Malignant Neoplasms of Brain
Peking Union Medical College Hospital 50
Not applicableStudy completedNCT00165542
What this trial is testing

A-protein Levels in Adult and Pediatric Brain Tumor Patients

Who this might be right for
Malignant Childhood Central Nervous System Neoplasm
Dana-Farber Cancer Institute 54
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Early research (Phase 1)Ended earlyNCT01989052
What this trial is testing

Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma

Who this might be right for
Malignant Glioma (WHO Grade III or IV)
Annick Desjardins 9
Large-scale testing (Phase 3)Looking for participantsNCT05770544
What this trial is testing

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.

Who this might be right for
Haematological MalignancyMalignancyMalignant Neoplasm+8 more
Cancer Research UK 30
Testing effectiveness (Phase 2)Study completedNCT00613093
What this trial is testing

Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic Glioma
Duke University 67
Post-approval studies (Phase 4)Study completedNCT05054998
What this trial is testing

Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid Neoplasm
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00541138
What this trial is testing

Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center 50
Early research (Phase 1)Study completedNCT00002988
What this trial is testing

Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 36
Testing effectiveness (Phase 2)Study completedNCT00498927
What this trial is testing

Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center 47
Testing effectiveness (Phase 2)Study completedNCT03520842
What this trial is testing

Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer

Who this might be right for
KRAS Gene MutationMetastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung Carcinoma+1 more
Stanford University 22
Early research (Phase 1)Study completedNCT00005637
What this trial is testing

Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01454596
What this trial is testing

CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII

Who this might be right for
Malignant GliomaGlioblastomaBrain Cancer+1 more
National Cancer Institute (NCI) 18
Not applicableLooking for participantsNCT06117930
What this trial is testing

Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research

Who this might be right for
Malignant Central Nervous System Neoplasm
Mayo Clinic 100
Testing effectiveness (Phase 2)Ended earlyNCT00003292
What this trial is testing

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Who this might be right for
ChondrosarcomaAdult FibrosarcomaAdult Leiomyosarcoma+3 more
SWOG Cancer Research Network 7
Next Page